Regional binding index of the radiolabeled selective 5-HT2A antagonist 123I-5-I-R91150 in the normal canine brain imaged with single photon emission computed tomography

Veterinary Radiology and Ultrasound

Volumn 44, Issue 3, 2003, Pages 344-351

  Peremans, K ^a   Audenaert, K ^b   Coopman, F ^a   Jacobs, F ^b   Dumont, F ^a   Slegers, G ^a   Verschooten, F ^a   Van Bree, H ^a   Mertens, J ^c   Dierckx, R ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

5 HT2a receptors; Brain; Dog; Scintigraphy; SPECT (single photon emission computed tomography)

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

DIAGNOSTIC AGENT; LIGAND; PIPERIDINE DERIVATIVE; R 91150; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BINDING COMPETITION; BRAIN; DOG; FEMALE; MALE; METABOLISM; REFERENCE VALUE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BINDING, COMPETITIVE; BRAIN; DOGS; FEMALE; IODINE RADIOISOTOPES; LIGANDS; MALE; PIPERIDINES; RADIOPHARMACEUTICALS; RECEPTORS, SEROTONIN; REFERENCE VALUES; SEROTONIN ANTAGONISTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0038824649     PISSN: 10588183     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2003.tb00467.x     Document Type: Article

References (40)

1. Stahl S. Essential Psychopharmacology. Cambridge, Cambridge University Press, 1996.
2. Ogren SO, Misane I. Animal models for studying serotonin (5-HT) receptor subtypes: relationship to 5-HT system pathologies. Nucl Med Biol 1998;25:747-749.
3. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. Cerebrospinal fluid metabolite levels in male arsonists. Arch Gen Psychiat 1987;44:241-247.
4. Virkkunen M, Goldman D, Nielsen D, Linnoila M. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiat Neurosci 1995;20:271-275.
5. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiat 1976;33:1193-1197.
6. Cremniter D, Kamain S, Kollenbach K, Alvarez JC, Lecrubier Y, Gilton A, Jullien P, Lesieur P, Bonnet F, Spreux-Varoquaux O. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biol Psychiat 1999;45:1572-1579.
7. Higley JD, Mehlman PT, Higley SB, Fernald B, Vickers J, Lindell SG, Taub DM, Suomi SJ, Linnoila M. Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxy-indoleacetic acid concentrations. Arch Gen Psychiat 1996;53:537-543.
8. Higley JD, Linnoila M. Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior: a nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann NY Acad Sci 1997;836:39-57.
9. Doudet D, Hommer D, Higley JD, Andreason PJ, Moneman R, Suomi SJ, Linnoila M. Cerebral glucose metabolism, CSF 5-Hiaa levels and aggressive behavior in rhesus monkeys. Am J Psychiat 1995;152:1782-1787.
10. Reisner IR, Mann JJ, Stanley M, Huang Y, Houpt KA. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and nonaggressive dogs. Brain Res 1996;714:57-64.
11. Olivier B, Mos J, Van Oorschot R, Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 1995;28:80-90.
12. Tecott LH, Julius DJ. A new wave of serotonin receptors. Curr Opin Neurobiol 1993;3:310-315.
13. Mengod G, Vilaro MT, Raurich A, Lopez-Gimenez JF, Cortes R, Palacios JM. 5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors. Histochem J 1996;28:747-758.
14. Lopez-Gimenez JF, Vilaro MT, Palacios J, Mengod G. Mapping of 5-HT2A receptors and their mRNA in monkey brain: (3H)MDL100.907 autoradiography and in situ hybridization studies. J Comp Neurol 2001;429:571-589.
15. Pazos A, Probst A, Palacios J. Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987;21:123-139.
16. Pazos A, Cortes R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 1985;346:231-249.
17. Hamada S, Senzaki K, Hamaguchi-Hamada K, Tabuchi K, Yamamoto H, Yamamoto T, Yoshikawa S, Okano H, Okado N. Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken. Molec Brain Res 1998;54:199-211.
18. Lingford-Hughes AR, Pilowsky LS. In vivo neuroreceptor imaging - methodology and applications in neuropsychiatry. In: De Deyn PP, Dierckx RA, Alavi A, Pickut BA (eds): SPECT in Neurology and Psychiatry. London, John Libbey & Company Ltd, 97, pp 89-106.
19. 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography in healthy subjects. Eur J Nucl Med 1997;24:119-124.
20. Hrdina PD, Demeter TB, Vu P, Sotonyi P, Palkovits M. 5HT uptake sites and 5HT2 receptors in brain of antidepressant-free suicide victims/depressives: increases in 5-HT2 sites in cortex and amygdala. Brain Res 1993;614:37-44.
21. Mann JJ, Stanley M, McBride PA, McEwen BS. Increased serotonin 2 and beta adrenergic receptor binding in the frontal cortex of suicide victims. Arch Gen Psychiat 1986;43:954-959.
22. Attar-Lévy D, Martinot J, Blin J, Cao-Castellana M, Crouzel C, Mazoyer B, Poirier M, Bourdel M, Aymard N, Syrota A, Féline A. The cortical serotonin-2 receptors studied with positron-emission tomography and 18F-setorperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiat 1999;45:180-186.
23. 11C-MDL 100907, a radioligand for selective imaging of 5HT2A receptors with positron emission tomography. Life Sci 1996;58:PL187-PL192.
24. Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek B, Brown GM. Wilson AA, Kennedy S. Prefrontal cortex (-HT2 receptors in depression: an [18F]setoperone PET imaging study, Am J Psychiat 1999;1029-1034.
25. Mertens J, Terriere D, Sipido V, Gommeren W, Janssen PMF, Leysen JE. Radiosynthesis of a new radioiodinated ligand for serotonin-5HT2-receptors, a promising tracer for gamma-emission tomography. J Label Compd Radiopharm 1995;34:795-801.
26. Terriere D, Janssen P, Gommeren W, Gysemans M, Mertens J, Leysen J. Evaluation of radioiodo-4-amino-N-(1-(4-fluorophenoxy)-propyl)-4-methyl-4- piperidinyl)-5-iodo-2-methoxybenzamide as a potential 5HT2 receptor tracer for SPE(C)T. Nucl Med Biol 1995;22:1005-1010.
27. 123I)R93274 as a SPECT radiotracer for imaging 5-HT2A receptors. Eur J Pharmacol 1997;321:285-293.
28. 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects. Eur J Nucl Med 1998;25:1617-1622.
29. 2a receptor binding index in deliberate self harm patients. Eur J Nucl Med 2001;28:175-182.
30. Van Laere K, Audenaert K, Dumont F, Vervaet M, Slegers G, Dierckx R, van Heeringen C. Frontal 5-HT2A binding potential is decreased in anorexia nervosa patients. J Nucl Med 2000;41:201 pp.
31. 123I-5-I-R- 91150. Br J Psychiat 1998;173:236-241.
32. 123I-5-I-R91150 in the normal dog. Nuc Med Comm 2002;23:1019-1027.
33. Peremans K, De Bondt P, Audenaert K, Van Laere K, Gielen I, Koole M, Versijpt J, Van Bree H, Verschooten F, Dierckx R. Regional brain perfusion in 10 healthy dogs measured using technetium-99m- ethyl cysteinate dimer SPECT: a normal database. Vet Radiol Ultrasound 2001;42:562-568.
34. Redding RW. Anatomy and physiology. In: Hoerlein BF (ed): Canine Neurology. 3. Philadelphia, London, Toronto, WB Saunders Co., 1978, pp 7-52.
35. Rosier A, Dupont P, Peuskens J, Bormans G, Vandenberghe R, Maes F, Schiepers C, Verbruggen A, Mortelmans L. Visualization of loss of 5-HT2A receptors with age in healthy using (18F) altanserin and positron emission imaging. Psychiat Res 1996;25:11-22.
36. Marcusson J, Morgan D, Winblad B, Finch C. Serotonin-2- binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res 1984;311:51-56.
37. 18F} altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res 1998;813:167-171.
38. Werner C. Effects of analgesia and sedation on cerebral blood flow, cerebral blood volume, cerebral metabolism, and intracranial pressure. Anaesthesist 1995;44:S566-S572.
39. Dormehl IC, Oliver DW, Hugo N. The primate model in neuropharmacology for cerebral blood flow determinations with HMPAO SPECT. In: De Deyn PP, Dierckx RA, Alavi A, Pickut BA (eds): A Textbook of SPECT in Neurology and Psychiatry. 1. London, John Libbey & Company Ltd, 1997, pp 521-536.
40. Ohata H, Iida H, Dohi S, Watanabe Y. Intravenous dexmedetomidine inhibits cerebrovascular dilation induced by isoflurane and sevoflurane in dogs. Anesth Analg 1999;89:370-377.